BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33978520)

  • 1. Attention and Motor Learning in Adult Patients with Neurofibromatosis Type 1.
    Castricum J; Tulen JHM; Taal W; Rietman AB; Elgersma Y
    J Atten Disord; 2022 Feb; 26(4):563-572. PubMed ID: 33978520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of ADHD on the cognitive and academic functioning of children with NF1.
    Pride NA; Payne JM; North KN
    Dev Neuropsychol; 2012; 37(7):590-600. PubMed ID: 23066937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor dysfunction in NF1: Mediated by attention deficit or inherent to the disorder?
    Haas-Lude K; Heimgärtner M; Winter S; Mautner VF; Krägeloh-Mann I; Lidzba K
    Eur J Paediatr Neurol; 2018 Jan; 22(1):164-169. PubMed ID: 29111114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relations between fine motor skill and parental report of attention in young children with neurofibromatosis type 1.
    Casnar CL; Janke KM; van der Fluit F; Brei NG; Klein-Tasman BP
    J Clin Exp Neuropsychol; 2014; 36(9):930-43. PubMed ID: 25284746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.
    Hyman SL; Arthur Shores E; North KN
    Dev Med Child Neurol; 2006 Dec; 48(12):973-7. PubMed ID: 17109785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive profile and disorders affecting higher brain functions in paediatric patients with neurofibromatosis type 1.
    Vaucheret Paz E; López Ballent A; Puga C; García Basalo MJ; Baliarda F; Ekonen C; Ilari R; Agosta G
    Neurologia (Engl Ed); 2019; 34(6):353-359. PubMed ID: 28431841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feedback-Based Learning of Timing in Attention-Deficit/Hyperactivity Disorder and Neurofibromatosis Type 1.
    Prochnow A; Bluschke A; Novotna B; von der Hagen M; Beste C
    J Int Neuropsychol Soc; 2022 Jan; 28(1):12-21. PubMed ID: 33573707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor impairment in children with Neurofibromatosis type 1: Effect of the comorbidity with language disorders.
    Iannuzzi S; Albaret JM; Chignac C; Faure-Marie N; Barry I; Karsenty C; Chaix Y
    Brain Dev; 2016 Feb; 38(2):181-7. PubMed ID: 26321374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention and Executive Disorders in Neurofibromatosis 1: Comparison Between NF1 With ADHD Symptomatology (NF1 + ADHD) and ADHD Per Se.
    Lion-François L; Herbillon V; Peyric E; Mercier C; Gérard D; Ginhoux T; Coutinho V; Kemlin I; Kassai B; Desportes V; Michael GA
    J Atten Disord; 2020 Nov; 24(13):1807-1823. PubMed ID: 28587546
    [No Abstract]   [Full Text] [Related]  

  • 12. Cognitive and motor control in neurofibromatosis type I: influence of maturation and hyperactivity-inattention.
    Huijbregts S; Swaab H; de Sonneville L
    Dev Neuropsychol; 2010; 35(6):737-51. PubMed ID: 21038163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ADHD in neurofibromatosis type 1.
    Mautner VF; Kluwe L; Thakker SD; Leark RA
    Dev Med Child Neurol; 2002 Mar; 44(3):164-70. PubMed ID: 12005317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive dysfunction in children with neurofibromatosis type 1.
    Rosser TL; Packer RJ
    Curr Neurol Neurosci Rep; 2003 Mar; 3(2):129-36. PubMed ID: 12583841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paired associate learning in children with neurofibromatosis type 1: implications for clinical trials.
    Payne JM; Barton B; Shores EA; North KN
    J Neurol; 2013 Jan; 260(1):214-20. PubMed ID: 22875098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor learning in children with neurofibromatosis type I.
    Krab LC; de Goede-Bolder A; Aarsen FK; Moll HA; De Zeeuw CI; Elgersma Y; van der Geest JN
    Cerebellum; 2011 Mar; 10(1):14-21. PubMed ID: 20927664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity to visual signals in neurofibromatosis type 1: is everything ok?
    Michael GA; Garcia S; Herbillon V; Lion-François L
    Neuropsychology; 2014 May; 28(3):423-8. PubMed ID: 24274026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive impairment in adults with neurofibromatosis type 1].
    Uttner I; Wahlländer-Danek U; Danek A
    Fortschr Neurol Psychiatr; 2003 Mar; 71(3):157-62. PubMed ID: 12624853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention to faces in social context in children with neurofibromatosis type 1.
    Lewis AK; Porter MA; Williams TA; Bzishvili S; North KN; Payne JM
    Dev Med Child Neurol; 2019 Feb; 61(2):174-180. PubMed ID: 29873078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular mechanisms of learning disabilities: a focus on NF1.
    Shilyansky C; Lee YS; Silva AJ
    Annu Rev Neurosci; 2010; 33():221-43. PubMed ID: 20345245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.